Notably, the inhibition of key enzymes involved in lipogenic pathways, such as stearoyl-CoA desaturase (SCD), fatty acid synthase (FASn), and acetyl-CoA carboxylase (ACC), has been linked to a reduced presence and proliferation of cancer stem cells (CSCs), which are critical for tumor growth and progression, in both in vitro and in vivo models (40, 41). Here, SCD is linked to neoplasm.